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Endomembrane trafficking has a key role for ensuring homeostasis, growth and development, hormonal
signaling, and adaptation of eukaryotes to the constantly changing environmental conditions. The complex
organization of the endomembrane system implies the need for searching novel tools to specifically probe
the regulatory components and dissect the tightly interconnected vesicle transport pathways. Here, we re-
view the large-scale chemical genetic screens, which led to the identification of small molecules with an
impact on various parts of the vesicle trafficking network. We discuss the similarities and differences in
the organization of the endomembrane systems in yeasts, mammals, and plants based on studies of small
molecules and their effects on trafficking hubs, routes, and conserved protein targets.Eukaryotic cells are characterized by functional compartmen-
talization of macromolecule trafficking, which is performed
by an elaborate and fine-tuned endomembrane system. The
endomembrane network comprises dynamic organelles with
discrete morphology, localization, and functions and ensures
both the secretion of biomolecules and the uptake of extracel-
lular material that is delivered to intracellular locations in a
highly coordinated manner. The exchange of cargo, membrane
components, and solutes between the cellular compartments
is a continuously ongoing process that involves alternating
steps of membrane deformation, budding, fission, tethering,
and fusion. The secretory and endocytic pathways are largely
interconnected at the level of common trafficking hubs and pro-
tein regulators, which substantially increases the complexity of
the endomembrane system. When key protein components of
the endomembrane system are compromised, pleiotropic phe-
notypes may occur, making it difficult to elucidate the underly-
ing molecular mechanism with classical genetic approaches.
Significant limitations of forward and reverse genetics are the
lack of phenotypic changes if functionally redundant compo-
nents of vesicular trafficking are analyzed and, in the opposite
case, the lethality of loss-of-function mutants due to the essen-
tial role of the intracellular transport for cell viability (Hicks and
Raikhel, 2012). An alternative approach that circumvents these
limitations deals with the use of small organic molecules as
specific effectors of endomembrane trafficking. An important
advantage of chemical genetics in dissecting complex biolog-
ical processes is the enormous diversity of chemical structures
that could be used for probing protein functions in a dose-
dependent and reversible manner (Kaschani and van der
Hoorn, 2007). Hence, it should be possible to perturb almost
any protein in a specific way, allowing the targeting of essential
genes. In addition, entire gene families can be targeted by
bioactive chemicals through perturbation of a common feature
of the corresponding proteins, thus addressing redundancy
among genes (Hicks and Raikhel, 2012; To´th and van der
Hoorn, 2010).Chemistry & BRecent advances in systems biology, bioinformatics, and
modern cell imaging opened novel opportunities for identifying
small molecules that can be used as tools to dissect endomem-
brane trafficking pathways. Here, we outline the progress in cur-
rent chemical genetics related to intracellular vesicle trafficking,
with an emphasis on the use of small molecules in plants, mam-
mals, and yeasts identified through high-throughput screens
(Figure 1). The central routes and hubs of the endomembrane
trafficking network in eukaryotic cells will be discussed for their
sensitivity to the compounds (Figure 2; Table 1), which is deter-
mined by the extent of conservation of the protein targets.
Endomembrane Trafficking Routes in Yeasts, Plants,
and Mammals: A Comparative View
The eukaryotic endomembrane system is composed of mem-
brane-delimited organelles, small vesicular compartments that
shuttle between those organelles, and a spectrum of transiently
associated, peripheral membrane components from the cytosol
that support, regulate, and define endomembrane trafficking
(Foresti and Denecke, 2008). Proteins that are cotranslationally
translocated into the endoplasmic reticulum (ER) are subse-
quently sorted for trafficking through the Golgi apparatus and
the trans-Golgi network (TGN). Anterograde transport from the
ER is mediated by COPII-coated vesicles, which fuse with pre-
Golgi intermediates to release their cargo, while Golgi-to-ER
protein recycling requires COPI vesicle formation. Unlike mam-
mals, the plant endomembrane system lacks an ER-Golgi
intermediate compartment (Foresti and Denecke, 2008). After
reaching the TGN, secretory proteins are packaged into secre-
tory vesicles and targeted to the plasma membrane (PM) (Va´z-
quez-Martı´nez et al., 2012). So far, the secretory route from the
TGN to the PM in plants is poorly understood. The TGN compart-
ment also produces clathrin-coated vesicles directed to the lytic
compartment (the lysosome inmammalian cells or the vacuole in
plants and yeasts). The latter route involves late endosomes
(LEs) in mammals, also called prevacuolar compartments/multi-
vesicular bodies (PVCs/MVBs) in plant cells. Unlike mammals,iology 20, April 18, 2013 ª2013 Elsevier Ltd All rights reserved 475
Figure 1. Forward and Reverse Chemical Genetic Screens across Yeasts, Plants, and Mammals
Forward chemical genetics is represented by cell-based and phenotypic-based screens. Reverse chemical genetics is represented by functionality-based,
in silico-based, and phenotypic-based screens. Only the relevant systems are shown for each screen.
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occur independently of clathrin (Scheuring et al., 2011). Traf-
ficking routes bypassing the LE/PVC/MVB compartment have
also been reported in yeasts, mammals, and plants (Dell’Angel-
ica, 2009; Feraru et al., 2010).
The endocytic pathway begins with invagination of the PM and
formation of clathrin-coated vesicles through membrane fission.
Similar to mammalian and yeast cells, clathrin-mediated endo-
cytosis (CME) appears to be an essential trafficking route in
plants, indicating the conservation throughout evolution (Chen
et al., 2011). Besides CME, growing evidence supports the
importance of clathrin-independent endocytosis in mammals,
yeasts, and plants (Howes et al., 2010; Li et al., 2012). Most of
the cargo internalized by endocytosis undergoes recycling
back to the PM. In contrast to mammals, the mechanisms of
PM protein recycling in plants are still obscure. A small fraction
of the endocytosed cargo is targeted for degradation to the lyso-
some by passing through early endosomes (EEs), which will
gradually maturate into LEs (Huotari and Helenius, 2011). Early
endosomes are subjected to gradual maturation to LEs (Huotari
and Helenius, 2011). Recently, the maturation-based sorting
model known from mammalian systems has been considered476 Chemistry & Biology 20, April 18, 2013 ª2013 Elsevier Ltd All rigin plants in which MVBs/LEs are most likely formed through
gradual transformation of parts of the TGN (Scheuring et al.,
2011).
An additional route to the lysosome and vacuole is provided by
autophagy. This process involves the enclosure of cellular con-
tents, such as long-lived proteins and organelles by a double
membrane structure to form vesicles, called autophagosomes,
which will eventually fuse with the lysosome or vacuole in order
to degrade their content. Autophagy is an essential process for
recycling cellular contents in yeasts, plants, and mammals (Li
and Vierstra, 2012; Yang and Klionsky, 2010). The identification
of autophagy-related (ATG) genes in Saccharomyces cerevisiae
and subsequently in other organisms revealed that themolecular
machinery responsible for autophagy seems to be well con-
served, although plants appear to have a much more diverse
array of ATG genes at their disposal (Li and Vierstra, 2012).
Although the fundamental mechanism of intracellular vesicle
trafficking appears to be conserved in eukaryotes, there are
several notable differences. In contrast to mammalian cells, the
TGN in plants is morphologically and functionally distinguished
from the trans Golgi cisternae (Viotti et al., 2010). A number of
experimental evidences revealed that the plant TGN possesseshts reserved
Figure 2. Schematic Representation of Major Trafficking Routes and Their Small-Molecule Effectors in Different Systems
Shown are a mammalian/yeast cell (left) and plant cell (right). Only endomembrane compartments relevant for this review are shown. Discussed small molecules
are indicated close to the compartment or route they affect. Dark blue, nucleus/ER; light blue, Golgi; yellow, EE (mammalian/yeast) or TGN (plants). Yellow to
green route, exocytic or recycling pathway with recycling endosomes; green to yellow route, endocytic pathway with endocytic vesicles maturating into EEs.
Yellow to red (lysosome/vacuole) route, LE and/or MVB maturation from EE into lysosome/vacuole. Dark blue to red route, Golgi/TGN-independent trafficking
from ER to vacuole. Gray (cytosol) to red route, autophagy. Note the absence of an autophagic route in the plant cell, since rapamycin has not been shown to
affect autophagy in plant cells yet.
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pathways. According to the latest model, the TGN in plants is
subdivided into domains where secretory vesicles are released
to the PM, into domains releasing clathrin-coated vesicles for re-
cycling to the PM and into domains that mature into MVBs
(Scheuring et al., 2011). Another specific feature of the yeast
and plant endomembrane systems is the vacuole, which in the
plant cell occupies up to 90% of the total cell volume (Surpin
and Raikhel, 2004). Two types of functionally distinct vacuoles
coexist in the plant cell, namely protein storage vacuoles
(PSVs) and lytic vacuoles, which are analogous to lysosomes
in mammalian cells (Zouhar and Rojo, 2009). The PSVs can be
distinguished by the presence of reserve proteins used mainly
during seed germination and by their neutral pH in contrast to
lytic vacuoles. However, the two types of plant vacuoles can
fuse and give rise to a large central vacuole (Frigerio et al., 2008).
In Search for Small-Molecule Modifiers of
Endomembrane Trafficking
Small bioactive molecules have long been used in medicine and
agriculture (Cong et al., 2012; Delaney et al., 2006). Recently,Chemistry & Blarge-scale systematic screens have boosted the search for
novel chemical regulators for mammalian drug discovery, and
this strategy is being rapidly adopted in plants (Hicks and
Raikhel, 2012; Knight and Shokat, 2007). Two types of chemical
genetics screens (forward and reverse) have been employed to
dissect the endomembrane trafficking in eukaryotes (Figure 1).
Forward chemical genetics uses growth phenotype- or cell-
based screens for inhibition or activation of a particular cellular
process, followed by molecular target identification. Growth
phenotype-based forward chemical genetics screens for endo-
membrane trafficking modulators have been recently carried
out in plants where a high-throughput screen based on the
germination and growth of tobacco pollen was used to interro-
gate more than 46,000 compounds (Drakakaki et al., 2011;
Robert et al., 2008). Other growth phenotypes related to endo-
membrane systems, such as gravitropic responses or cell elon-
gation during hypocotyl growth, were also used in chemical
genetics screens (Codreanu et al., 2012; Surpin et al., 2005).
The cell-based screens often employ the use of fluorescent
marker proteins as readouts for activity or inhibition of trafficking
pathways. Examples from the mammalian systems are theiology 20, April 18, 2013 ª2013 Elsevier Ltd All rights reserved 477
Table 1. Small Molecule Effectors of Endomembrane Trafficking Identified through Large-Scale Chemical Genetic Screens
Name Structure
Affected Endomembrane
Compartment Known Target Screen References
Chemical Effectors of Exocytosis/Secretion/Anterograde Trafficking
Exo1 ER to Golgi trafficking fluorescence-based
imaging screen of
VSV-Gts trafficking
Feng et al., 2003
Exo2 ER to Golgi trafficking,
Golgi, TGN
Arf-GEF GBF1 fluorescence-based
imaging screen of
VSV-Gts trafficking
Spooner et al., 2008
LG186 Golgi Arf-GEF GBF1 Boal et al., 2010
AG1478 cis-Golgi P58-YFP-based screen
in H4 human
glioblastoma cells
Pan et al., 2008
LG8 ER, Golgi Exo2 analog screen for
activity in A. thaliana
Sorieul et al., 2011
Golgicide A Golgi Arf-GEF GBF1 luciferase-based toxin
susceptibility screen
Sa´enz et al., 2009
AMF-26 cis- and trans-Golgi COMPARE-guided
in silico screening
Ohashi et al., 2012
LM11 Golgi, endosomal
structures
Arf1-GDP/ARNO
complex
in silico structure-based
screen
Viaud et al., 2007
Secramine B Golgi to PM trafficking Rho GTPase Cdc42 fluorescence-based
imaging screen of
VSV-Gts trafficking
Pelish et al., 2006
Chemical Effectors of Endocytosis/Retrograde Trafficking
Tyrphostin A23 endocytosis interfering between
tyrosine motifs and
AP2 complex
screen for tyrosine
kinases
Yaish et al., 1988
Dynasore endocytosis dynamin dynamin GTPase activity
inhibitor screen
Macia et al., 2006
Pitstop 1 endocytosis clathrin terminal
domain (TD)
ELISA-based screen for
inhibition of amphiphysin
and clathrin TD association
von Kleist et al., 2011
Pitstop 2 endocytosis clathrin TD ELISA-based screen for
inhibition of amphiphysin
and clathrin TD association
von Kleist et al., 2011
16D10 endosomes, lysosomes likely inhibition of
V-ATPases or as
proton ionophore
fluorescence-based
imaging screen of
VSV-Gts trafficking
Nieland et al., 2004
(Continued on next page)
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Table 1. Continued
Name Structure
Affected Endomembrane
Compartment Known Target Screen References
Comp. 75 early retrograde
transport
luciferase-based toxin
susceptibility screen
Saenz et al., 2007
Comp. 134 recycling endosomes
to Golgi, retrograde
transport
luciferase-based toxin
susceptibility screen
Saenz et al., 2007
Retro-1 EE to TGN retrograde
trafficking
screen for inhibitors of
ricin toxicity
Stechmann et al., 2010
Retro-2 EE to TGN retrograde
trafficking
screen for inhibitors of
ricin toxicity
Stechmann et al., 2010
Ferristatin increased transferrin
receptor internalization
and degradation
fluorescence-based
screen for calcein
quenching
Brown et al., 2004
ES1 endosomes screen for pollen tube
growth and germination
inhibitors
Robert et al., 2008
ES5 endosomes, recycling screen for pollen tube
growth and germination
inhibitors
Drakakaki et al., 2011
Chemical Effectors of Vacuolar Trafficking and Autophagy
Sortin 1 vacuolar traffic and
morphology
screen for mistargeting of
carboxypeptidase Y
Zouhar et al., 2004
Sortin 2 vacuolar traffic and
morphology
screen for mistargeting of
carboxypeptidase Y
Zouhar et al., 2004
Sortin 3 vacuolar traffic and
morphology
screen for mistargeting of
carboxypeptidase Y
Zouhar et al., 2004
Gravacin ER to vacuole trafficking PGP19 screen for gravitropic
response
Surpin et al., 2005
C834 vacuolar trafficking screen for pollen tube
growth and germination
inhibitors
Rivera-Serrano et al., 2012
(Continued on next page)
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Table 1. Continued
Name Structure
Affected Endomembrane
Compartment Known Target Screen References
Vacuolin-1 induction of vacuole
formation, inhibition of
exocytic PM-lysosome
fusion
fluorescence-based
imaging screen of
VSV-Gts trafficking
Cerny et al., 2004
SMER 10 enhancer of autophagy cytotoxicity screen in
yeast and autophagy
substrate clearance in
mammals
Sarkar et al., 2007
SMER 18 enhancer of autophagy cytotoxicity screen in
yeast and autophagy
substrate clearance in
mammals
Sarkar et al., 2007
SMER 28 enhancer of autophagy cytotoxicity screen in
yeast and autophagy
substrate clearance in
mammals
Sarkar et al., 2007
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fibroblast cells infected with GFP-fused vesicular stomatitis virus
(VSVGts-GFP) (Feng et al., 2003), the screen for inhibitors of
endocytosis based on transferrin (Tf) receptor-mediated iron
uptake in HeLa cells measured by the quenching of calcein fluo-
rescence (Brown et al., 2004), and the screen for inhibitors of
Golgi-mediated trafficking based on the expression of the yellow
fluorescent protein (YFP)-tagged Golgi-residing protein p58 (Pan
et al., 2008). Several screens based on autophagosomemarkers
coupledwith either GFP or luciferase have assessed the ability of
small molecules to affect autophagy (Balgi et al., 2009; Farkas
et al., 2009, 2011; Zhang et al., 2007). Flow cytometry has also
been used to quantify fluorescent protein-based sensors for
autophagic and endolysosomal activities in a screen for auto-
phagy modulators (Hundeshagen et al., 2011). In plants, PM pro-
teins or other endomembrane compartment markers tagged
with fluorescent proteins have been used as markers to identify
compounds affecting endocytosis, recycling, or vacuolar mor-
phogenesis (Codreanu et al., 2012; Drakakaki et al., 2011; Rob-
ert et al., 2008; Surpin et al., 2005).
Cell-based screens for endomembrane trafficking modulators
can also employ other readouts, such as cell viability, enzymatic
reactions, or secretion. For example, cytotoxicity measurements
using destabilized firefly luciferase (Saenz et al., 2007) or radio-
active-labeled amino acids (Stechmann et al., 2010) were used
in screens for inhibitors of retrograde trafficking of toxins (shiga,
cholera, and ricin) in mammalian cells. Small-molecule en-
hancers and inhibitors of autophagy were identified in a screen
for their ability to affect the clearance of the autophagy substrate
A53T a-synuclein in mammalian cells (Huang et al., 2004; Sarkar
et al., 2007). In yeasts, high-throughput immunoassays for
detection of missecreted carboxypeptidase Y have been per-
formed to screen for bioactive compounds that interfere with
the sorting of lytic enzymes to the vacuolar lumen (Zouhar
et al., 2004).
Reverse chemical genetics searches for compounds that
inhibit or activate in vitro proteins known to be involved in a480 Chemistry & Biology 20, April 18, 2013 ª2013 Elsevier Ltd All rigdefinite process followed by further characterization of the
phenotypic effects at cellular and/or organism level (Figure 1).
In comparison to forward chemical genetics, this approach has
the significant advantage of bypassing the target identification
step. This strategy has been successful in identifying chemical
modulators of protein trafficking components involved in early
steps of CME, such as Dynasore and Pitstops (Macia et al.,
2006; von Kleist et al., 2011).
Because of the available large collections of deletion mutants,
the yeast S. cerevisiae has become a powerful tool for small
molecule discovery by using synthetic lethality (reviewed by
Roemer et al., 2012). Synthetic lethality screens were used to
identify inhibitors of exocytosis (Zhang et al., 2010) and the traf-
ficking between the TGN and the endosomes (Duncan et al.,
2007). Whole-genome yeast deletion collections have also
been screened for responses to chemical libraries in diverse
environmental conditions, where genes involved in endomem-
brane trafficking and vacuolar degradation were found essential
for resistance to multiple compounds (Hillenmeyer et al., 2008).
Alternative in silico screening approaches have enabled the
search for novel exocytosis inhibitors in mammals. A virtual
screen has been designed to specifically probe the interaction
between the ADP-ribosylation factor 1 (ARF1) guanosine triphos-
phatase (GTPase) and its guanine exchange factor (GEF) ARNO
based on known crystal structures of their complex (Viaud et al.,
2007). Drug sensitivity databases have also been exploited to
find novel inhibitors of ARF1 GTPase activation based on func-
tional correlation with compoundswith already known properties
(Ohashi et al., 2012).
Chemical Effectors of Exocytosis/Secretion/
Anterograde Trafficking
In the early 2000s, only very few small molecule modulators
of the secretory pathways were known. The best example
of such an inhibitor of secretion in mammalian cells is the
fungal macrocyclic lactone Brefeldin A (BFA), which has
been instrumental for studying the function of the Golgihts reserved
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mechanism of BFA action in mammalian cells have revealed
that this compound impedes the interaction between different
members of the ARF GTPase family and their associated large
GEFs and, thus, causes a diversity of effects, including tubula-
tion of EEs, redistribution and fusion of the TGN with EEs, and
fusion of the ER with the Golgi (Dinter and Berger, 1998; Renault
et al., 2003). In contrast to mammalian and yeast systems,
plants, for example, Arabidopsis, have only large ARF-GEFs, of
which some are resistant to BFA (Anders and Ju¨rgens, 2008).
In plants, BFA has been described as an inhibitor of either secre-
tory or endocytic pathways, depending on where in the cell the
BFA-sensitive ARF-GEFs are residing (Nebenfu¨hr et al., 2002;
Robinson et al., 2008). Chemical genetics has been used to
search for small molecules with more specific effects on exocy-
tosis thanBFA inmammalian systems (Feng et al., 2003; Figure 2;
Table 1). Two compounds structurally different from BFA, Exo1
and Exo2, were found to inhibit the traffic from the ER to the
Golgi. Although the direct targets of Exo1 and Exo2 are not
known, their mode of action differs from that of BFA (Feng
et al., 2003, 2004). Treatment with either Exo1 or Exo2 induces
reversible redistribution of Golgi material back to the ER without
any concomitant effects on endocytic pathways. In contrast to
BFA, Exo1 does not directly inhibit ARF-GEFs and has less effect
on the organization of the TGN (Feng et al., 2003). The effect of
Exo2 on the Golgi and the TGN is similar to that of BFA, except
that it does not induce tubulation and merging of the TGN and
endosomal compartments (Feng et al., 2004; Spooner et al.,
2008). Therefore, it was proposed that Exo2 is more selective
than BFA, possibly inhibiting the function of only the cis-Golgi-
residing ARF-GEF, GBF1. A modified version of Exo2, LG186,
was further developed in order to increase selectivity toward
GBF1 (Boal et al., 2010). Another chemical modifier of GBF1
activity, AG1478, was also found to preferentially target the
cis-Golgi in human cell lines (Pan et al., 2008).
In contrast to mammalian cells, Exo2 was not active in plant
cells (Sorieul et al., 2011). Screening a number of Exo2 deriva-
tives revealed LG8 as an active analog in Arabidopsis root cells
that causes severe changes in the morphology of the ER and
the Golgi but not the post-Golgi compartments. Unlike BFA,
the intracellular targets of LG8 in plants still remain elusive (Sor-
ieul et al., 2011).
A high-throughput screen for small molecules that inhibit the
toxin retrograde transport has identified an inhibitor of protein
secretion called Golgicide A (GCA) (Saenz et al., 2007, Sa´enz
et al., 2009). GCA exhibits BFA- and LG186-like effects by spe-
cifically targeting GBF1 (Boal et al., 2010; Sa´enz et al., 2009).
Other recently identified exocytosis inhibitors, such as AMF-26
and LM11, have been designed to specifically impair the interac-
tion between the ARF1 GTPase and its GEFs in mammals.
Although the chemical structure of AMF-26 differs from that of
BFA, this compound induces disruption of the cis- and trans-
Golgi, targeting the activation of ARF1 GTPase (Ohashi et al.,
2012). To date, BFA is known to inhibit only large but not small-
and medium-sized ARF-GEFs (Anders and Ju¨rgens, 2008).
Conversely, LM11 targets the interaction between ARF1 and
ARNO, a BFA-insensitive human ARF-GEF. This compound
has been shown to induce changes in the Golgi similar to those
provoked by BFA; however, it leads to the formation of largeChemistry & Bendosomal structures differing from the phenotype observed
after BFA treatment (Viaud et al., 2007).
The mechanisms of regulation of the anterograde transport
from the Golgi to the PM have been approached with the help
of Secramine (Pelish et al., 2006). In mammalian cells, this com-
pound has been shown to perturb the protein export from the
Golgi by inhibiting the activation of Cdc42, revealing the essen-
tial role of this Rho GTPase for vesicle trafficking. In particular,
Secramine targets the association of Cdc42 with its guanine
dissociation inhibitor RhoGDI1 and prevents binding of this
Rho GTPase to the Golgi membranes.
Chemical Effectors of Endocytosis/Retrograde
Trafficking
A common way to interfere with endocytosis in mammals and
plants (Irani and Russinova, 2009; Robinson et al., 2008) is the
use of Tyrphostin A23, a lowmolecular weight compound, which
has originally been identified in a chemical screen for inhibitors of
protein tyrosine kinases (Yaish et al., 1988). It has been found
that Tyrphostin A23 perturbs the interaction between the AP-2
adaptor complex and consensus tyrosine-containing motifs
in the cytosolic domain of PM cargoes, leading to a block of
cargo-sorting in clathrin-coated vesicles (Banbury et al., 2003).
Tyrphostin A23 inhibits both endocytosis and vesiculation at
the TGN in plants (Robinson et al., 2008). Although the function
of the plant AP-2 complex is most likely conserved in plants,
the target of Tyrphostin A23 has not yet been defined. Neverthe-
less, the use of this compound has been instrumental in studies
of CME in plants (Irani et al., 2012; Ortiz-Zapater et al., 2006).
CME in mammals has been successfully approached by
means of reverse chemical genetics (Figure 2; Table 1), which
has been facilitated by the considerable knowledge about the
CME machinery in this system. Dynasore has been identified
as a noncompetitive and reversible inhibitor of the GTPase
activity of dynamin, a protein essential for vesicle formation in
CME and caveolae-mediated trafficking (Macia et al., 2006).
Dynasore arrests the progression of vesicle coat assembly and
the subsequent uncoating. Most of the plant genomes encode
dynamin-related proteins, some of which might function in
CME (Fujimoto and Ueda, 2012). A recent study on the intracel-
lular trafficking of the fungal protein elicitor receptor, LeEix2,
demonstrated the use of Dynasore for blocking endocytosis in
plant cells (Sharfman et al., 2011).
Two structurally different compounds, Pitstop 1 and Pitstop 2,
have also been used to elucidate the mechanisms of clathrin-
coated pit formation in mammals (von Kleist et al., 2011). Pit-
stops have been found to compete with clathrin box-containing
accessory proteins for a common binding site on the terminal
domain of the clathrin heavy chain. Interference with the function
of this domain does not affect clathrin recruitment, but Pitstops
severely perturb clathrin-coated pit dynamics, due to the inability
of clathrin to bind regulatory proteins required for progression in
vesicle maturation. Similar to Dynasore, Pitstops induce the
accumulation of endocytic intermediates at the PM, representing
different stages of this trafficking route. Pitstop 2 was shown to
be effective in blocking the internalization of PM cargo markers,
like the Tf receptor and the epidermal growth factor in mamma-
lian cells, through selective impairment of CME (von Kleist et al.,
2011). A recent report has indicated that, in addition to CME,iology 20, April 18, 2013 ª2013 Elsevier Ltd All rights reserved 481
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thrin-independent endocytic pathways (Dutta et al., 2012).
Several compounds identified through forward chemical
genetics have been found to target endosomal compartments
from the endocytic pathway downstream of the PM. A group of
sulfonamides (with a representative member, the compound
16D10) was identified in the Exo screen (Feng et al., 2003) and
shown to affect trafficking from the Golgi to the PM (Nieland
et al., 2004). Although the protein target of this group is unknown,
it is likely that sulfonamides exert their action indirectly by
suppressing the vacuolar H+-ATPase (V-ATPase) function, or
directly as proton ionophores (Nieland et al., 2004). Chemical
screens for inhibitors of endocytosis of toxins (shiga, cholera,
and ricin) in mammalian cells facilitated the identification of com-
pounds specifically affecting the retrograde toxin trafficking at
the level of recycling endosomes and the Golgi (compound 75
and 134) (Saenz et al., 2007) or the EEs and TGN (Retro-1 and
Retro-2) (Stechmann et al., 2010) level.
Receptor-mediated endocytosis in mammals has been
tackled with the use of Ferristatin, which is a selective inhibitor
of Tf-mediated iron uptake (Brown et al., 2004; Horonchik and
Wessling-Resnick, 2008). Interestingly, Ferristatin has led to
the discovery of an endocytic route for the PM-localized Tf
receptor by inducing its enhanced internalization in a clathrin-
independent manner (Horonchik and Wessling-Resnick, 2008).
In plants, the limonoid Endosidin 1 (ES1) has been found to
induce selective intracellular accumulation of some but not all
PM cargoes (Robert et al., 2008). ES1 specifically blocks the
trafficking of PM proteins at the level of TGN/EEs. Another com-
pound from the Endosidin series, named ES5, has recently been
implicated in the inhibition of PM protein recycling in both plant
and mammalian cells (Drakakaki et al., 2011).
Chemical Effectors of Vacuolar Trafficking and
Autophagy
Studies of vacuolar transport and biogenesis have been
approached, for the first time, by forward chemical screens in
yeast because of the conserved trafficking machinery between
yeasts and plants (Zouhar et al., 2004; Figure 2; Table 1). Three
compounds, called Sortin1, Sortin2, and Sortin3, induced secre-
tion of the vacuolar protein carboxypeptidase Y in yeast and
affected the morphology of Arabidopsis or yeast vacuoles (Zou-
har et al., 2004). Although the targets of Sortins are not identified,
evidence has been provided that Sortin1 targets the crosstalk
between vacuolar biogenesis and transport (Rosado et al.,
2011), whereas Sortin2 and Sortin3 affect vacuolar trafficking,
possibly by inhibition of the endosomal trafficking (Chanda
et al., 2009; Norambuena et al., 2008). Another small molecule
linked to vacuolar trafficking is gravacin, which strongly inhibits
gravitropism in Arabidopsis and blocks the trafficking of tono-
plast markers to the vacuolar membrane by a yet unknown
mechanism (Surpin et al., 2005).
Larger chemical genetic screens in plants have revealed
several more small molecules affecting PM cargo trafficking to
the vacuole or vacuolar morphogenesis, the targets of which
remain to be identified (Drakakaki et al., 2011). For example,
apart from perturbing the recycling pathway, ES5 has been
proven to severely enhance the vacuolar accumulation of PM
proteins (Drakakaki et al., 2011). Another compound derived482 Chemistry & Biology 20, April 18, 2013 ª2013 Elsevier Ltd All rigfrom the same screen, namely C834, has been instrumental in
identifying two distinct transport routes to the vacuole used by
de novo-synthesized tonoplast intrinsic proteins (Rivera-Serrano
et al., 2012).
A compound derived from the Exo screen (Feng et al., 2003),
named Vacuolin-1, has been shown to induce the formation of
large swollen vacuoles in different mammalian cell types through
fusions of endosomes and lysosomes (Cerny et al., 2004).
In mammals and yeast, extensive research has gone into iden-
tifying small-molecule effectors of autophagy.One of the best ex-
amples of small molecules affecting autophagy is rapamycin, the
well-known inhibitor of the phosphatidylinositol kinase target of
rapamycin (TOR) (Noda andOhsumi, 1998). Screens for chemical
modifiers of rapamycin identified several small-molecule inhibi-
tors and small-molecule enhancers of rapamycin (SMER) with
an effect on autophagy in yeast andmammalian systems (Sarkar
et al., 2007). Despite previous reports (Mahfouz et al., 2006),
plants are sensitive to rapamycin (Xiong and Sheen, 2012); how-
ever, in contrast to mammals and yeasts, no direct link between
rapamycin and autophagy has yet been shown in plants.
Special Considerations when Analyzing Drug-Induced
Endomembrane Trafficking Phenotypes
Growing evidence suggests that, when targets of endomem-
brane effectors are not known, the interpretation of the observed
phenotypes should account for possible effects of the com-
pounds on the cytoskeleton dynamics. The endosomal matura-
tion inmammalian cells is dependent on themicrotubule network
(Hehnly and Stamnes, 2007), as disruption of microtubules leads
to dispersal of LEs and lysosomes throughout the cytoplasm
(Huotari and Helenius, 2011). In turn, formation and motility of
EEs and concurrent sorting of internalized proteins for either
recycling or lysosomal degradation are largely dependent on
the actin dynamics (Boulant et al., 2011; Ohashi et al., 2011).
Similarly, stabilizing actin in plant cells by using chemicals inter-
feres with endocytosis and vesicle transport (Dhonukshe et al.,
2008). Examples exist where the observed endomembrane traf-
ficking phenotype in the presence of a bioactive compound is
not due to disturbance of the function of an endomembrane
protein but rather is a result of a modulation of the cytoskeleton
organization. This is illustrated by the endocytic inhibitor ES1,
also called prieurianin (Robert et al., 2008; To´th et al., 2012).
Recent findings suggest that ES1 acts primarily as an actin sta-
bilizer by an unknown mechanism without affecting the microtu-
bules, thus possibly inhibiting intracellular vesicle movement.
The effect of ES1 on actin dynamics has been observed in
both plants and mammals, pointing to conservation of its
molecular target in eukaryotes (To´th et al., 2012). Another
example concerns the use of Secramine, which affects the
cellular functions of the Rho GTPase Cdc42 and, in this way,
impairs the Golgi-to-PM vesicle trafficking but also inhibits actin
polymerization (Pelish et al., 2006). Taken together, these exam-
ples corroborate the need to routinely test chemical compounds
for direct effect on the cytoskeleton. Another consideration in
studying endomembrane trafficking through chemical biology
is the necessity to discriminate between primary compound-
specific effects and general changes in the cellular homeostasis.
Because all steps of intracellular vesicle trafficking are ATP- or
GTP-dependent, energy depletion induced by the compoundhts reserved
Figure 3. Distribution of Discussed Small Molecules with Activity in
Mammalian, Yeast, and Plant Systems
Small molecules are distributed according to overall activity, thus not specific
to endomembrane compartments.
Chemistry & Biology
Reviewhit would lead to a global disruption of the endomembrane sys-
tem. Notably, cytotoxicity assays, such as those dealing with
ATP content determination, could reveal the borderline dose
and time of exposure, beyond which the compound hit induces
unspecific responses (Thorne et al., 2010).Perspectives and Future Challenges
Small molecules are powerful tools in deciphering highly dy-
namic and essential cellular processes, such as endomembrane
trafficking. However, the subsequent identification of the molec-
ular targets that underlie the observed phenotype remains a
major challenge. Unlike medical research, the rate of compound
target discovery in plant-based chemical genetic studies is still
limited (To´th and van der Hoorn, 2010). Although forward genetic
screens for compound resistance remain a favorite approach for
target identification in plants, in most cases, only downstream
components of the pathway in which the compound acts are
identified (Hicks and Raikhel, 2012). Affinity chromatography is
an alternative powerful tool to identify proteins that physically
interact with the compound (Frei et al., 2012), which still remains
to be demonstrated in plants. Various compound deconvolution
strategies have recently been developed, mostly in the human
drug discovery field (Cong et al., 2012; Ho et al., 2011). Recent
progress includes advances in chemoinformatics, providing
increasingly fast and reliable computational tools to predict po-
tential targets for orphan bioactive ligands to identify off-targets
responsible for side effects and to propose novel targets of
existing drugs (Laggner et al., 2012; Lounkine et al., 2012).
Although the use of computational approaches for activity
profiling of compounds in plants is limited by the insufficient
structural biology data (Kumari and van der Hoorn, 2011), one
can apply existing in silico ligand profiling methods to availableChemistry & Bstructural data of other eukaryotes and then translate the pre-
dicted model to plants. Proteomics tools can also provide in-
sights on the effect of small molecules at the whole proteome
level, as exemplified by BFA (Taka´c et al., 2011), or at the level
of individual organellar proteomes, as reported in mammals and
plants (Drakakaki et al., 2012; Steuble et al., 2010). Furthermore,
small-molecule targets identification can also benefit from
coupling chemical genomics with semiautomated image acqui-
sition and image analysis, which will allow us to assess quanti-
tative differences in the phenotype caused by individual com-
pounds (Ung et al., 2012).
However, compounds might have more than one target. One
example in plants is gravacin, a compound that appears to
have an effect both on the ER-to-vacuole trafficking through an
unknown mechanism and on gravitropic responses through
modulating the activity of a PM transporter (Rojas-Pierce et al.,
2007; Surpin et al., 2005). Even when a small molecule has
been optimized to specifically inhibit a certain target, other
off-target effects might still be observed. This is exemplified by
Pitstop 2, which, apart from inhibiting clathrin-mediated endocy-
tosis (von Kleist et al., 2011), also appears to affect clathrin-inde-
pendent endocytosis via an unknown mechanism (Dutta et al.,
2012). Hence, a deeper understanding of the actionmechanisms
of newly described compounds is required.
The discernible degree of conservation of a number of endo-
membrane trafficking components in eukaryotes (Dacks et al.,
2008) evokes one’s expectations for the existence of universal
chemical moieties impacting common vesicle transport routes.
Many classical endomembrane trafficking inhibitors commonly
used in mammalian systems have been successfully introduced
as valuable tools in plant cell research (Figures 2 and 3). In turn,
the validation of the intracellular effects of plant-specific inhibi-
tors in mammalian cell cultures, as shown for ES5 and ES1/
prieurianin (Drakakaki et al., 2011; To´th et al., 2012), opens novel
opportunities for translating the knowledge obtained from plant-
based screens to human drug discovery. Ultimately, it would be
tempting to define a set of general principles for using informa-
tion derived from large-scale chemical genetic screens to deci-
pher the evolution of the endomembrane system in eukaryotes.
However, the evolutionary aspect of small molecules’ specificity
is closely related to the mode of action of the compound and the
conservation of the respective binding sites. Small molecules
can affect conserved proteinmotifs and remain active in different
species (exemplified by BFA). In contrast, trafficking regulators,
such as Exo 2 (Feng et al., 2004; Spooner et al., 2008), that target
specifically a group of proteins in one kingdom are not neces-
sarily active toward evolutionary conserved proteins in other
eukaryotes, possibly due to speciation events. It remains to be
seen if natural products (e.g., BFA) are more evolutionary spe-
cific compared to small molecules from large combinatorial (syn-
thetic) libraries. Thus, addressing the degree of evolutionary
specificity of a compound would require a thorough character-
ization of the small molecule mode of action.ACKNOWLEDGMENTS
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